RT Journal Article
SR Electronic
T1 Bombesin-Targeted PET of Prostate Cancer
JF Journal of Nuclear Medicine
JO J Nucl Med
FD Society of Nuclear Medicine
SP 67S
OP 72S
DO 10.2967/jnumed.115.170977
VO 57
IS Supplement 3
A1 Rosalba Mansi
A1 Ryogo Minamimoto
A1 Helmut Mäcke
A1 Andrei H. Iagaru
YR 2016
UL http://jnm.snmjournals.org/content/57/Supplement_3/67S.abstract
AB Imaging plays an important role in prostate cancer (PC), including accurate evaluation of the extent of disease, assessment of sites of recurrent disease, and monitoring of response to treatment. Molecular imaging techniques are among the novel developments related to the imaging of PC, and various SPECT and PET radiopharmaceuticals are now available in clinical trials or commercially. Here we describe the preclinical and clinical use of gastrin-releasing peptide receptors as targets for the imaging of PC, with a focus on the development of PET tracers for the imaging of gastrin-releasing peptide receptor–positive tumors.